Coronary Disease
Novo Nordisk reported that the ZEUS study, which involved more than 6,300 patients with heart disease or advanced kidney disease, failed to show a benefit for ziltivekimab vs placebo. Ziltivekimab lowered interleukin-6 and C-reactive protein,...
This international consensus document from the European Society of Cardiology (ESC), American College of Cardiology (ACC), American Heart Association (AHA), and World Heart Federation (WHF) updates myocardial infarction (MI) classification...
The authors present a case of post-myocardial infarction ventricular pseudoaneurysm repair with mitral valve replacement and coronary revascularization performed through a minimally invasive left anterior minithoracotomy via the fourth intercostal...
This single-center retrospective study evaluated whether stenosis in the intervening left anterior descending artery (iLAD), between the internal thoracic artery (ITA) anastomosis and diagonal bifurcation, affects ITA-LAD graft events after...
Across 252,408 angiograms performed by 40 interventional cardiologists in British Columbia (2010–2024), the proportion of patients referred for coronary artery bypass grafting (CABG) varied 13-fold (2.03 percent–26.4 percent) and was...
Using period hypercapnea as a surrogate “contrast” agent, myocardial oxygenation was assessed using cardiac MR and accurately mapped areas of relative ischemia.
...An interesting metanalysis, especially: The ad hoc results of off-pump surgery. The mean number of silent brain infarcts per patient was significantly higher in the transcatheter aortic valve implantation group...
Ticagrelor (Brilinta), an oral P2Y12 inhibitor, is an agent used in combination with aspirin for dual antiplatelet therapy after coronary interventions. It’s antiplatelet function cannot be reversed by platelet transfusion....
The authors prospectively analyzed right ventricular (RV) function in 109 patients undergoing a broad range of cardiac surgeries. RV function was assessed at several time points by evaluating TAPSE and...
This single-center study retrospectively analyzed the impact of the implementation of thromboelastography (TEG) on all cardiac procedures performed during 2-year intervals prior to and after TEG implementation. A total of...
Five highlights in the CDC’s most recent Health, United States report, based on data from 1999 to 2017: Black patients were more than twice as likely as Asians or Pacific...
The American College of Cardiology’s 68th Annual Scientific Session has released the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. This guideline includes newly generated recommendations for control...
An important review in a mainstream periodical read by cardiologist colleagues.
...



